4.6 Article

Ginsenoside Rg3-enriched Korean Red Ginseng extract attenuates Non-Alcoholic Fatty Liver Disease by way of suppressed VCAM-1 expression in liver sinusoidal endothelium

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Vitamin C alleviates alcoholic liver injury by suppressing neutrophil infiltration in senescence marker protein 30-knockout mice irrespective of its antioxidant effects

Su-Min Baek et al.

Summary: This study found that vitamin C significantly alleviated ethanol-mediated liver disease in vitamin C-deficient ethanol-fed mice group by suppressing neutrophil infiltration and reducing CD68-positive cell infiltration. The attenuating effect of vitamin C on neutrophil infiltration in the liver is associated with its protective effect on ethanol-mediated intestinal damage in vitamin C-deficient ethanol-fed mice.

LIFE SCIENCES (2022)

Review Plant Sciences

Functional roles and mechanisms of ginsenosides from Panax ginseng in atherosclerosis

Qianqian Xue et al.

Summary: Atherosclerosis is a major cause of cardiovascular diseases and addressing it is crucial for reducing societal burden. Ginsenosides, natural compounds obtained from ginseng, have shown pharmacological activities against various diseases including atherosclerosis.

JOURNAL OF GINSENG RESEARCH (2021)

Review Endocrinology & Metabolism

NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment

Giovanni Targher et al.

Summary: NAFLD is strongly associated with an increased risk of cardiovascular events and other cardiac complications, independently of traditional CVD risk factors. The risk of CVD and other cardiac/arrhythmic complications parallels the severity of NAFLD, with multiple underlying mechanisms likely contributing to this increased risk.

DIABETES & METABOLISM (2021)

Review Biochemistry & Molecular Biology

Treatments for NAFLD: State of Art

Alessandro Mantovani et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease globally, and management strategies include lifestyle changes, controlling metabolic risk factors, correcting modifiable risk factors, and preventing complications. Over the past decade, various potential agents have been investigated for treating NAFLD and its advanced forms, shedding some light but also casting shadows on their effectiveness.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Gastroenterology & Hepatology

Alcohol-induced Hsp90 acetylation is a novel driver of liver sinusoidal endothelial dysfunction and alcohol-related liver disease

Yilin Yang et al.

Summary: The study demonstrates that liver sinusoidal endothelial cells can metabolize alcohol, revealing the mechanism of alcohol-induced LSEC dysfunction and liver injury. A potential therapeutic strategy involves blocking acetylation of Hsp90 specifically in LSECs via adeno-associated virus-mediated gene delivery to ameliorate alcohol-induced liver injury.

JOURNAL OF HEPATOLOGY (2021)

Article Pharmacology & Pharmacy

Rg3 promotes the SUMOylation of SERCA2a and corrects cardiac dysfunction in heart failure

Zhihao Liu et al.

Summary: This study revealed a novel role of ginsenoside Rg3 in the abnormal Ca2+ cycle in cardiomyocytes of mice with heart failure, showing improvements in cardiac function and Ca2+ homeostasis, mediated by an increase in SUMOylation level and SERCA2a activity. SUMO1 plays a crucial role in mediating the protective effect of Rg3. The findings suggest that drug intervention targeting the SUMOylation of SERCA2a could offer a novel therapeutic strategy for heart failure treatment.

PHARMACOLOGICAL RESEARCH (2021)

Review Medicine, Research & Experimental

Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions

Samar H. Gerges et al.

Summary: NAFLD is a disorder characterized by excessive fat accumulation in the liver, which can progress to NASH, accompanied by inflammation and fibrosis. The pathophysiology of NAFLD and NASH involves a complex interplay between metabolic, environmental, and genetic factors. Currently, there is no FDA-approved treatment for NAFLD and NASH, with off-label medications and hepatoprotective agents being used instead.

LIFE SCIENCES (2021)

Review Gastroenterology & Hepatology

Sinusoidal endotheliopathy in nonalcoholic steatohepatitis: therapeutic implications

Samar H. Ibrahim

Summary: Liver sinusoidal endothelial cells (LSECs) play a crucial role in the pathogenesis and progression of nonalcoholic fatty liver disease (NAFLD) by undergoing capillarization and expressing adhesion molecules. They regulate hepatic immune cell populations by mediating leukocyte subset adhesion in NAFLD, highlighting their role in the inflammatory response.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2021)

Review Biochemistry & Molecular Biology

Current Options and Future Directions for NAFLD and NASH Treatment

Chunye Zhang et al.

Summary: NAFLD is a common chronic liver disease with a range of severity from simple steatosis to NASH. Reprogramming antidiabetic and anti-obesity drugs is a major treatment option, targeting hepatic inflammation, fibrosis, and cell death. There is ongoing clinical trials to evaluate various drugs for the treatment of NAFLD, NASH, and liver fibrosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Peripheral Vascular Disease

Free fatty acid receptor 4 activation protects against choroidal neovascularization in mice

Yohei Tomita et al.

ANGIOGENESIS (2020)

Review Pharmacology & Pharmacy

Relationship Between Ginsenoside Rg3 and Metabolic Syndrome

Hyunji Lee et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Biochemistry & Molecular Biology

Pro-Resolving Effect of Ginsenosides as an Anti-Inflammatory Mechanism of Panax ginseng

Dong-Soon Im

BIOMOLECULES (2020)

Review Biochemistry & Molecular Biology

Characteristics of Panax ginseng Cultivars in Korea and China

Hao Zhang et al.

MOLECULES (2020)

Review Gastroenterology & Hepatology

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Konstantin Kazankov et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL-17 and TNF in mice

Alexander Wree et al.

HEPATOLOGY (2018)

Review Pathology

Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease

Juan Pablo Arab et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)

Review Gastroenterology & Hepatology

Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity

Shishir Shetty et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Integrative & Complementary Medicine

Anti-Inflammatory Activity of Rg3-Enriched Korean Red Ginseng Extract in Murine Model of Sepsis

Evelyn Saba et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)

Review Gastroenterology & Hepatology

Liver sinusoidal endothelial cells: Physiology and role in liver diseases

Johanne Poisson et al.

JOURNAL OF HEPATOLOGY (2017)

Review Gastroenterology & Hepatology

Non-alcoholic fatty liver disease: The diagnosis and management

Shehab M. Abd El-Kader et al.

WORLD JOURNAL OF HEPATOLOGY (2015)

Review Plant Sciences

Ginseng in Traditional Herbal Prescriptions

Ho Jae Park et al.

JOURNAL OF GINSENG RESEARCH (2012)

Article Chemistry, Multidisciplinary

Targeted transfection increases siRNA uptake and gene silencing of primary endothelial cells in vitro - A quantitative study

Sigridur A. Asgeirsdottir et al.

JOURNAL OF CONTROLLED RELEASE (2010)

Review Immunology

Liver architecture, cell function, and disease

Hiromi Ishibashi et al.

SEMINARS IN IMMUNOPATHOLOGY (2009)

Review Medicine, General & Internal

Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome

Chin Hee Kim et al.

CLEVELAND CLINIC JOURNAL OF MEDICINE (2008)

Article Gastroenterology & Hepatology

Benefits of lifestyle modification in NAFLD

Stephen A. Harrison et al.

Article Gastroenterology & Hepatology

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

DE Kleiner et al.

HEPATOLOGY (2005)

Review Medicine, General & Internal

Medical progress - Nonalcoholic fatty liver disease

P Angulo

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Pharmacology & Pharmacy

Endothelial cells in culture: A model for studying vascular functions

T Bachetti et al.

PHARMACOLOGICAL RESEARCH (2000)